Press "Enter" to skip to content

FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices

FDA informs companies that the agency is not approving their PMA applications and that they will have to remove their products from the market

Original source:

Also Read:   FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system